Outpatient Therapy for Febrile Neutropenia: Clinical and Economic Implications

Author： de Lalla F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.6, 2003-01, pp. : 397-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Economic Considerations of Empirical Antibacterial Therapy of Febrile Neutropenia in Cancer

By Dranitsaris G.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 343-353

Adis International

Access to resources Recommend Favorite

Outpatient treatment of febrile neutropenia is viable

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Outpatient Management of Febrile Neutropenia in Children with Cancer

By Holdsworth M.T.  

Pediatric Drugs, Vol. 5, Iss. 7, 2003-01 ,pp. : 443-455

Adis International

Access to resources Recommend Favorite

Voriconazole: appropriate empirical therapy in febrile neutropenia?

By  

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Critical appraisal of clinical practice guidelines for adult cancer patients with febrile neutropenia

By  

International Journal Of Pharmacy Practice, Vol. 26, Iss. 1, 2018-02 ,pp. : 49-54

John Wiley & Sons Inc

Access to resources Recommend Favorite